SCHEDULE: Federated Hermes Reports 8.4% Stake in LifeMD

Federated Hermes, Inc. and associated entities have reported beneficial ownership of 8.4% of LifeMD's common stock as of September 30, 2026.

Summary

• Federated Hermes, Inc., along with the Voting Shares Irrevocable Trust and individuals Thomas R. Donahue, Ann C. Donahue, and J. Christopher Donahue, have filed an amendment to their Schedule 13G.
• The filing indicates beneficial ownership of 4,049,974 shares of LifeMD's common stock.
• This ownership represents 8.40% of the class of securities.
• The reporting date for this ownership is September 30, 2026.
• The filing clarifies that this is not an admission of beneficial ownership for the securities held by managed funds and beneficial ownership is expressly disclaimed for those securities.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports changes in beneficial ownership and does not contain operational or financial performance updates.

Positives

• Significant institutional ownership reported by Federated Hermes, Inc., indicating potential investor confidence.
• Clear disclosure of beneficial ownership stake (8.4%) in LifeMD.

Negatives

• The filing does not provide any financial performance data or operational updates for LifeMD, limiting insight into the company's current health.

Risks

• The filing does not explicitly mention any risks associated with LifeMD's operations or the reporting entities' investment strategy.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding LifeMD's future performance.

Management Comments

• In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes in public companies. This filing indicates Federated Hermes, Inc. has taken a notable position in LifeMD, which operates in the telehealth and healthcare services sector.

Stakeholder Impact

• Shareholders: May view the increased institutional ownership as a positive sign, potentially leading to greater scrutiny and support for the company's strategy.

Next Steps

• Continued monitoring of LifeMD's performance and any further filings by Federated Hermes, Inc.

Key Dates

Keywords

LifeMD, Federated Hermes, Schedule 13G, Beneficial Ownership, Common Stock, Investment Company, Investment Adviser, Holding Company